RYMGX Mutual Fund

RYMGX Mutual Fund (S&P MidCap 400 Pure Growth Fund Class A) is managed by Guggenheim Investments with $7.3M in net assets. RYMGX expense ratio is 1.54%, holding 97 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 2004-09-01.

RYMGX performance shows a YTD return of 14.07%. The 1-year return is 18.22% and the 5-year return is 4.83%.

RYMGX top holdings include Arrowhead Pharmaceuticals Inc (2.5%), Strl Sterling Infrastructure Inc. (2.3%), Carpenter Technology Corpcommon Stock (2.2%), Technipfmc Plc Ordinary Shares (2.2%), Halozyme Therapeutics Inc (2.1%). Go to all RYMGX holdings, RYMGX sectors, or RYMGX dividends.

RYMGX can be compared against other funds. Use RYMGX overlap to find shared positions, or RYMGX vs another fund for a side-by-side view. RYMGX alternatives are available via the screener, along with tax-loss harvesting opportunities.